| Literature DB >> 33931670 |
Sofia Cuoco1, Arianna Cappiello1, Alfonso Scarpa2, Donato Troisi2, Maria Autuori1, Sara Ponticorvo2, Claudia Cassandro3, Renzo Manara2, Fabrizio Esposito2, Gabriella Santangelo4, Paolo Barone1, Ettore Cassandro2, Maria Teresa Pellecchia5,6.
Abstract
Few studies have investigated the neuropsychological profile of Hearing Loss (HL) subjects and the effects of hearing-aid on cognitive decline. We investigated the neuropsychological profile of HL patients at baseline and compared the neuropsychological profiles of patients with and without hearing-aid at 6 month. Fifty-six HL patients and 40 healthy subjects (HC) underwent neuropsychological and behavioral examination and were compared at baseline. Changes at follow-up were compared between HL patients with (N = 25) and without (N = 31) hearing-aids. At baseline, significant differences between HL and HC were found in MOCA test, Raven's Coloured Progressive Matrices (CPM) and SF-36. Among mild-HL patients, patients with hearing-aid significantly improved on the Clock Drawing Test (CDT) as compared to patients without hearing-aid. Our findings indicate that hearing loss is associated with both a reduced efficiency of the global cognitive state and a worse quality of life as compared to HC, supporting the association between HL and cognitive impairment. Moreover, only patients with mild-HL shows some cognitive improvement after using hearing-aid, suggesting that rehabilitative strategies may be more effective to delay cognitive decline in such patients. However, we cannot exclude that hearing-aids may affect cognitive decline in more severe-HL, but a longer follow-up is needed.Entities:
Year: 2021 PMID: 33931670 PMCID: PMC8087665 DOI: 10.1038/s41598-021-88487-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic, neuropsychological and behavioral features in HL patients and healthy controls.
| HL patients | HC | P | |
|---|---|---|---|
| Age, years | 64.26 ± 7.97 | 63.22 ± 6.33 | 0.405 |
| Age of education | 10.92 ± 4.87 | 11.27 ± 4.69 | 0.749 |
| CPM | 25.60 ± 6.05a | 29.94 ± 6.34a | |
| MOCA-total | 21.05 ± 4.6a | 23.67 ± 3.45a | |
| 15-RAWTL-immediate recall | 33.26 ± 11.11 | 38.97 ± 10.03 | |
| 15- RAWTL-delayed recall | 6.41 ± 2.83 | 8.00 ± 3.05 | |
| ROCF memory | 13.21 ± 6.55 | 13.77 ± 6.21 | 0.652 |
| ROCF copy | 29.49 ± 7.30 | 32.10 ± 4.55 | 0.170 |
| CDT | 11.01 ± 13.54 | 9.55 ± 0.98 | 0.406 |
| TMT-A | 48.92 ± 27.04 | 48.57 ± 14.88 | 0.298 |
| Odct | 49.07 ± 8.30 | 50.56 ± 7.01 | 0.493 |
| BDI-II | 8.83 ± 8.89 | 4.84 ± 4.73 | |
| DAS-total | 21.21 ± 9.77 | 18.69 ± 7.96 | 0.231 |
| DAS-executivel | 6.28 ± 4.72 | 5.00 ± 4.58 | 0.174 |
| DAS-emoziona | 7.67 ± 4.08 | 6.73 ± 3.56 | 0.275 |
| DAS-initiation | 7.26 ± 4.57 | 6.96 ± 4.34 | 0.940 |
| Sf-36 physical function | 74.73 ± 25.46 | 79.20 ± 29.70 | 0.190 |
| Sf-36 role limitations due to physical problems | 55.03 ± 40.76 | 73.95 ± 37.93 | |
| Sf-36 bodily pain | 52.10 ± 31.57a | 73.95 ± 23.25a | |
| Sf-36 general health perception | 47.67 ± 23.48a | 65.41 ± 17.49a | |
| Sf-36 emotional wellbeing | 49.55 ± 23.10a | 66.45 ± 14.48a | |
| Sf-36 social functioning | 63.75 ± 28.93 | 84.62 ± 19.25 | |
| Sf-36 role limitations due to emotional problems | 59.96 ± 42.36 | 84.62 ± 31.12 | |
| Sf-36 general mental health perception | 55.74 ± 23.82a | 74.91 ± 13.12a |
Statistically significant differences are indicated in bold. The trend towards statistical significance is indicated in italics.
15-RAWLT Rey’s auditory 15-word learning test- Verbal immediate recall; 15-RAWLT, Rey’s auditory 15-word learning test- Verbal delayed recall; BDI-II; Beck Depression Inventory II;CDT, Clock Drawing Test; CPM, Raven's Coloured Progressive Matrices; DAS, Dimensional Apathy Scale; HC, Healthy controls; HL, hearing loss; IQR, Interquartile ranges; MOCA, Montreal Cognitive Assessment; N, simple size; oDCT, Digit Cancellation Test; ROCF, Rey-Osterrieth Complex Figure Test; SF 36, Short form 36; TMT-A, Trail Making Test Part A.
aHL patients vs HC corrected for p ≤ 0.004.
Delta (T1 – T0) values for neuropsychological and behavioral variables in HL patients with and without hearing aids.
| HL patients with aids | HL patients without aids | P | |
|---|---|---|---|
| Age, years | 62.64 ± 7.89 | 65.58 ± 7.93 | 0.168 |
| Age of education | 10.80 ± 4.83 | 11.00 ± 4.98 | 0.822 |
| CPM | − 2.04 ± 6.42a | 1.58 ± 3.42a | |
| MOCA-total | − 0.08 ± 2.98 | 0.06 ± 3.39 | 0.941 |
| 15-RAWTL-immediate recall | 1.80 ± 8.39 | 3.35 ± 6.87 | 0.525 |
| 15-RAWTL-delayed recall | 1.20 ± 1.82 | 0.80 ± 2.54 | 0.893 |
| ROCF memory | 4.54 ± 8.27 | 0.22 ± 6.12 | |
| ROCF copy | − 0.62 ± 3.76 | − 0.50 ± 3.70 | 0.698 |
| CDT | 0.00 ± 1.00 | − 3.16 ± 18.25 | 0.962 |
| TMT-A | − 1.64 ± 18.11 | 3.74 ± 16.54 | 0.158 |
| oDCT | 1.16 ± 12.53 | − 1.22 ± 6.87 | 0.980 |
| BDI-II | − 2.91 ± 9.13 | − 1.90 ± 9.61 | 0.518 |
| DAS-total | 14.29 ± 19.32 | 0.31 ± 25.98 | |
| DAS-executive | 0.33 ± 5.08 | − 0.44 ± 4.21 | 0.222 |
| DAS-emotional | − 1.37 ± 3.93 | 1.82 ± 5.55 | |
| DAS-initiation | 0.95 ± 4.81 | 0.72 ± 5.33 | 0.693 |
| Sf-36 physical function | − 3.80 ± 23.64 | − 5.96 ± 33.07 | 0.712 |
| Sf-36 role limitations due to physical problems | 8.08 ± 40.33 | − 2.41 ± 50.56 | 0.636 |
| Sf-36 bodily pain | 9.52 ± 32.14 | − 4.22 ± 35.82 | 0.077 |
| Sf-36 general health perception | − 3.32 ± 22.18 | − 2.25 ± 18.44 | 0.954 |
| Sf-36 emotional wellbeing | − 1.4 ± 27.21 | 1.61 ± 21.77 | 0.690 |
| Sf-36 social functioning | 4.84 ± 33.82 | − 2.77 ± 32.16 | 0.310 |
| Sf-36 role limitations due to emotional problems | 6.80 ± 50.02 | 0.09 ± 53.06 | 0.647 |
| Sf-36 general mental health perception | − 2.00 ± 30.73 | 2.32 ± 22.71 | 0.707 |
Statistically significant differences are indicated in bold.
15-RAWLT Rey’sauditory 15-word learning test- Verbal immediate recall; 15-RAWLT, Rey’sauditory 15-word learning test- Verbal delayed recall; BDI-II, Beck Depression Inventory II; CDT, Clock Drawing Test; CPM, Raven's Coloured Progressive Matrices; DAS, DimensionalApathy Scale; HL, hearing loss; IQR, Interquartile ranges; MOCA, Montreal Cognitive Assessment; N, simplesize;oDCT, DigitCancellation Test; ROCF, Rey-OsterriethComplex Figure Test;; SF 36, Short form 36; T0 = base-line; T1 = Follow up; TMT-A, TrailMaking Test Part A.
aHL patients with aids vs HL patients without aids, corrected for p ≤ 0.0125.
Significant differences in delta (T1 − T0) values for neuropsychological and behavioral variables in HL patients with and without hearing aids divided according to the severity of HL .
| HL patients with aids | HL patients without aids | P | |
|---|---|---|---|
| CDT | 1 | − 1.66 | |
Statistically significant differences are indicated in bold.
CDT, Clock Drawing Test; CPM, Raven's Coloured Progressive Matrices; DAS, Dimensional Apathy Scale; HL, hearing loss; N, simple size; PTA, pure tone audiometric; ROCF memory, Rey-Osterrieth Complex Figure Test; T0, base-line; T1, Follow up.